By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


Teva Pharmaceutical Industries Ltd. develops, produces and markets ethical drugs, generic drugs, and fine chemicals for the pharmaceutical industry and disposable products for hospitals and home care services.




Founders: Chaim Salomon, Moshe Levin, and Yitschak Elstein

CEO: Erez Vigodman

CEO Global Operations: Carlo de Notaristefani

CEO Global Specialty Medicines: Rob Koremans

CEO Global Generic Medicines: Sigudur (Siggi) Olafsson

CFO: Eyal Desheh

CMO (Medical):

CSO (Scientific): Michael Hayden


Please click here for Teva Pharma job opportunities.


Please click here for clinical trial information.


All Products

Key Statistics

Ownership: Public

Web Site: Teva
Employees: 5,700
Symbol: TEVA


Company News
Why Exiting the Generics Biz or a Break Up Could Save Troubled Teva (TEVA) 9/20/2017 5:46:54 AM
Teva (TEVA) And Nuvelution Pharma Partner To Accelerate Development Of AUSTEDO (Deutetrabenazine) Tablets For Use In Tourette Syndrome In The United States 9/19/2017 11:12:12 AM
Teva (TEVA) Completes Amendment To Credit Facilities 9/19/2017 7:43:12 AM
Teva (TEVA) Gains Another $2.48 Billion For Selling The Last Of Its Women’s Health Portfolio 9/18/2017 6:42:03 AM
Teva (TEVA) To Present Data For AUSTEDO (Deutetrabenazine) Tablets And Other Research At The 2017 Psych Congress 9/15/2017 7:37:36 AM
Debt-Ridden Teva (TEVA) Gets Ready to Unload Another Asset Worth $800 Million 9/14/2017 6:24:03 AM
Teva (TEVA) Receives FDA Priority Review For First Line Use Of TRISENOX (Arsenic Trioxide) In Patients With Low To Intermediate Risk Acute Promyelocytic Leukemia (APL) 9/12/2017 7:36:48 AM
Teva (TEVA) Announces Sale Of PARAGARD (Intrauterine Copper Contraceptive) To CooperSurgical 9/12/2017 7:34:39 AM
New Teva (TEVA) CEO Brings Experience And This Secret Weapon 9/12/2017 6:42:29 AM
Teva (TEVA) Stock Continues Soaring On New CEO And $1.1 Billion Sale Of Its Contraceptive Brand 9/12/2017 6:33:31 AM